PROTIA INC. Logo

PROTIA INC.

Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.

303360 | KO

Overview

Corporate Details

ISIN(s):
KR7303360002
LEI:
Country:
South Korea
Address:
서울특별시 강서구 양천로 401, 강서한강자이타워 A동 702호, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PROTIA INC. is an in vitro diagnostics (IVD) company that designs, develops, and manufactures a wide range of diagnostic kits and instruments. Leveraging patented technologies and proteomics-based biomarker research, the company offers solutions across multiple medical fields, including allergy, point-of-care testing (POCT), infectious diseases, autoimmune disorders, cancer, and animal diagnostics. PROTIA is particularly recognized for its high-performance multiplex allergy diagnostic kits, such as the PROTIA Allergy-Q series. The company also developed the world's first total IgG quantitative POCT kit using whole blood. In addition to its products, PROTIA provides specialized protein analysis and custom research services, including protein identification, characterization, and rapid kit development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-12 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-22 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-07-18 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.5 KB
2025-05-09 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.4 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 18.4 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.3 MB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.9 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.9 KB
2025-01-24 00:00
Regulatory News Service
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.0 KB
2025-01-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 188.1 KB

Automate Your Workflow. Get a real-time feed of all PROTIA INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTIA INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTIA INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.